Biopôle is a life sciences community bringing together industry and academia, based in Lausanne, Switzerland. It offers a world-class combination of infrastructure, added value services, living space and community engagement.

While Biopôle is open to all therapeutic areas, the main focus is on developing innovative solutions in the fields of oncology, immunology and personalised medicine.

Biopôle SA, the management and promotion organisation for the park, was established in 2004 as a limited company by the public authorities of the Canton of Vaud.

Examples

Clinical Bioinformatics for personalized medicine

To coordinate bioinformatics analysis pipelines for data across hospitals in Switzerland, helping health professionals to make use of this clinically-useful knowledge.

A new way to treat colon cancer

Vitamin A can treat resistant colon cancer, preventing cancerous stem cells of the colon from growing uncontrollably and spreading.

Cubosomes for the controlled release of molecules

Scientists were able to study the 3D structure of cubosomes in detail for the first time for possible future use in medicine and food science.

A far-red DNA stain for live-cell nanoscopy

By combining two molecules, scientists have developed a DNA stain that that can be used to safely image living cells.

On site

LifeScience

Personalized medicine

The medical discipline that strives to the customization of healthcare, with medical decisions, practices, and/or products being tailored to the individual patient’s needs all across the healthcare value-chain. By concentrating their work on the knowledge of the human being and illness, with the patient as the main actor, researchers aim to develop new therapeutic solutions, and to improve the diagnostic tools, the prevention, the quality of treatment, help and support for patients.

Neurosciences

Aiming at engineering the nervous system to improve sensation, cognition, and mobility. Neurosciences strives to create solutions for new markets using bioengineering and neuro-prosthetics to improve human lives. Leading cutting edge research in different neuroscience areas is only possible by studying, in particular, the standard or pathological behaviours of the brain, both in human beings (adults or children) and animals.

Immunology

Renowned expertise in vaccine development including therapeutic and preventive vaccines against pathogens, chronic diseases and allergies. Innovative approaches focused on vaccine formulation and virus-based vaccines and immuno-engineering.

Oncology

Innovative technologies to better diagnose and treat cancer using state-of-the-art knowledge and platforms to discover biomarkers and develop efficient small molecules, antibodies and cell therapies.

Professors and experts

Georges Coukos

Ludwig Cancer Research, Georges Coukos Lab

Tumor Immunology
T cell therapies
Cancer vaccines
Bioinformatics and egineering

 

Partners

Université de Lausanne (UNIL)

The University of Lausanne is composed of seven faculties, 14,300 students and 3,000 researchers. In an international atmospere, the UNIL emphasises on an interdisciplinary approach, with close cooperation between students, teaching staff, and professors. The UNIL is renowned for its innovative teaching methods.

Centre Hospitalier Universitaire Vaudois (CHUV)

The University Hospital of Lausanne (CHUV) is one of the 5 Swiss university hospitals. Through its collaboration with the Faculty of Biology and Medicine of the University of Lausanne, the CHUV plays an important role in european advances for medical care, medical research and training. The CHUV employs 10’000 collaborators of 113 nationalities.

 

HES-SO

The largest University of Applied Science in Switzerland comprises 28 schools of higher education with 19’400 students and six faculties for Design and Fine Arts, Business Management and Services, Engineering and Architecture, Music and Performing Arts, Health and Social Work.

ISREC

The independent ISREC Foundation is focused on supporting innovative cancer research in Lausanne and western Switzerland, in particular at the frontier of translational oncology that has promised to positively impact the future treatment of human cancer.

Swiss Institute of Bioinformatics

SIB is a nonprofit organization federating 65 Swiss research and service groups expert in bioinformatics. SIB’s 800 scientists join forces to advance biomedical research by providing life scientists and clinicians with state-of-the-art bioinformatics resources, expertise, trainings, and services.